Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Half-year Report January - June 2024

· Net revenue from property management was SEK 1,049 million (1,004), an increase of 5 per cent. Including intra-Group rental revenue, net revenue from property management was SEK 1,147 million (1,101).   · Gross profit from property management increased by 4 per cent, totalling SEK 701 million (675). Including intra-Group rental revenue, gross profit from property management was SEK 799 million (771).   · Net result for the period was SEK -354 million (-1,372), equivalent to SEK -1.75 per share(-6.78). The negative result can be attributed to negative unrealised changes

Qt Group Plc Managers' Transactions Tuukka Turunen

Qt Group Plc, Stock exchange release, August 22, 2024, at 1:00PM EESTQt Group Plc - Managers' Transactions____________________________________________Person subject to the notification requirementName: Tuukka TurunenPosition: Other senior managerIssuer: Qt Group PlcLEI: 743700GO2XU2ZYYDKW67Notification type: INITIAL NOTIFICATIONReference number: 75100/4/4 ____________________________________________Transaction date: 2024-08-21Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000198031Nature of transaction: DISPOSAL  Transaction details(1):

EQT INFRASTRUCTURE VI, THROUGH OTELLO BIDCO AB, HAS OBTAINED ALL NECESSARY REGULATORY APPROVALS AND ANNOUNCES ADDITIONAL ACQUISITIONS SECURING 70.12 PERCENT OF THE SHARES IN OX2 AB (PUBL)

This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this announcement and in

Research from Karolinska University Hospital Reveals New Findings on Women's Fertility

New discoveries about follicles, the cell pouches in women's ovaries, may be important for future treatment of infertility.A new study from Karolinska University Hospital shows that there are two types of immature follicles in a woman's ovaries, and that they probably have different tasks. According to the researchers, only one type of follicle is involved in developing eggs. The other seems instead to be entirely devoted to secreting hormones, a process called signaling. The discovery may have an impact on how we assess female fertility in the future and how we treat involuntary

Notification of major holding in Kindred Group plc

Kindred Group plc (Kindred) hereby announces that it, on 21 August 2024, has received a notification of major holding from The Goldman Sachs Group, Inc., a company with its registered office in Wilmington, USA. The notification refers to a decrease in the number of shares and voting rights in Kindred held by The Goldman Sachs Group.According to the notification, the Goldman Sachs Group held 0.16% of the shares and voting rights in Kindred as of 16 August 2024. The relevant chain of controlled undertakings can be found in the notification, of which a copy can be found on Kindred’s website:

Borr Drilling Limited – Adjustment conversion price convertible bonds

Hamilton, Bermuda, August 22, 2024 Reference is made to Borr Drilling Limited’s (“Borr Drilling” or the “Company”) (NYSE and OSE: ”BORR”) stock exchange releases related to the distribution to shareholders of $0.10 per share as announced on August 14, 2024 (the “Dividend”).  In accordance with the loan agreement for the Company's USD 250,000,000 5% Senior Unsecured Convertible Bonds 2023/2028, ISIN NO0012828187, the Dividend has triggered an adjustment to the conversion price from USD 7.1347 to USD 7.0249 per share.

Leqembi (lecanemab) authorized for early Alzheimer’s disease in Great Britain

Stockholm, Sweden August 22, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (brand name, generic name: lecanemab) has been granted Marketing Authorization by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain, for the treatment of mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD) in adult patients that are apolipoprotein E ε4 (ApoE ε4)[1] heterozygotes or non-carriers.[2] Lecanemab becomes the first the medicine which targets an underlying cause of the disease, to be authorized in a

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B82YXW83 Issuer Name VESUVIUS PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name BlackRock, Inc. City of registered office (if applicable) Wilmington Country of registered office (if applicable) USA 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above   City

NADMED raises €3.5M to bring NAD tests to international markets, advancing personalized treatment options

Finnish biotech company NADMED has developed the first test to measure all four bodily forms of vitamin B3, called NADs, and glutathiones directly from fresh blood in hours, with the highest accuracy on the market. NADMED provides crucial information on vitamin B3 deficiencies, which have been linked to degenerative age-related diseases such as metabolic diseases, cancer, neurodegenerative and heart diseases.HELSINKI, Finland (August 22nd, 2024) Finnish biotech company NADMED  has closed a €3.5M series A round to fund its entry into the U.S. and other international

Invitation to monthly digital events and presentations of quarterly reports

Hamlet BioPharma is pleased to announce the continuation of the digital event series this autumn. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during the Q&A sessions that will follow each presentation. Please visit our web page to join the digital events: https://hamletbiopharma.com/series-of-digital-events-2024/   The digital event are scheduled for: · September 18th, 2024, 12:00 CET · October 23rd, 2024, 12:00 CET · December 11th, 2024, 12:00 CET   Additionally, please

Novel AI algorithm assists in breast cancer screening

Researchers at the University of Eastern Finland have developed a novel artificial intelligence based algorithm, MV-DEFEAT, to improve mammogram density assessment. This development holds promise for transforming radiological practices by enabling more precise diagnoses. High breast tissue density is associated with an increased risk of breast cancer, and breast tissue density can be estimated from mammograms. The accurate assessment of mammograms is crucial for effective breast cancer screening, yet challenges such as variability in radiological evaluations and a global shortage of

Arctic Bioscience – Invitation to presentation of half year 2024 results

Arctic Bioscience will publish its financial results for the first half year of 2024 on Thursday 29[th] of August, at 08:00 CET.The same day at 11:00 CET, the Company will host a webcast to present the results and give an operational update. Following the presentation, it will be opened for questions from the audience. Webcast details: Date: Thursday 29[th] of August 2024 Time: 11:00 CET Format: Webcast and Q&A Language: English The presentation can be accessed through the Company’s website, or with the link below: Link: https://channel.royalcast.com/landingpage/

Webstep ASA: Exercise window for share options

Oslo, 22 August 2024: With reference to the stock exchange announcement by Webstep ASA (the “Company”) of 18 November 2019, in which it was announced that Webstep ASA granted employee share options as part of the Company’s long-term incentive programme (“LTIP”).The Company will conduct a window on 28 August - 29 August 2024, in which the option holders may exercise share options. The total amount of vested options is 529,621 options, of which 341,151 options are in the money as of 21 August 2024 and exercisable for the option holders.

Allgon Welcomes Claes Seth as its New CTO

After 17 years of service since 2007 at Tele Radio and Allgon, Jesper Ribbe has decided to leave Allgon by the end of 2024. Jesper played a key role in the success of both organizations, at steering wheel of the technology and R&D departments.Claes Seth will take over the position of Chief Technology Officer, bringing in a plethora of experience in Research & Development in senior positions. Coupled to this experience, Claes also brings a proven record of wireless technologies, telecommunications, embedded software & systems, and team leadership & development to the table at Allgon’s senior

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 22.08.2024, 11:00 AMManagers' transactions Viking Line Abp has received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from aperson discharging managerial responsibilities in Viking Line Abp. Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Fredrik VojbackePosition: Member of the Board/Deputy member Issuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49Notification type: INITIAL NOTIFICATIONReference number:

International SOS / Medaire launch new digital Maritime Risk Map with Risk Intelligence data for their luxury yacht members

Risk Intelligence A/S (“Risk Intelligence” or the “Company") announces that its data is now available on International SOS / Medaire Maritime Risk Map for its luxury yacht members.Risk Intelligence is pleased to announce that its security data is now available to International SOS / Medaire luxury yacht members via a brand-new digital platform. The purpose is to provide a comprehensive one-stop shop for vessel and crew safety and wellbeing. The Maritime Risk Map contains Risk Intelligence threat assessments for countries, cities and marinas which can be accessed by members. Read more about

Internet Vikings Approved to Offer VMware Private Cloud Hosting in Arizona

Internet Vikings , a licensed in-state hosting provider for iGaming and online sports betting, has received official approval from the Arizona Department of Gaming to launch its VMware-based private cloud hosting solutions. This achievement allows the company to provide secure and scalable hosting for licensed operators taking sports betting wagers across Arizona, fully complying with the Arizona Administrative Code (A.A.C). This builds on Internet Vikings' success in May 2023, when the company became the first online sports betting hosting provider

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 182 – 22 AUGUST 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 171/24 and 173/24, respectively. Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Martin Badsted, Chief Financial Officer, tel.: +45 33 42 05 26, e-mail: mba@norden.com

PulPac appoints Marcus Palm as new Vice President

PulPac, the company behind the pioneering Dry Molded Fiber technology, is pleased to announce the appointment of Marcus Palm as its new Vice President. Marcus has been an active board member of PulPac since 2019 and now steps into a strategic leadership role, bringing extensive experience in legal affairs, licensing, and business strategy.[En bild som visar person, klädsel, Människoansikte, hushållspapper Automatiskt genererad beskrivning]   Marcus Palm, newly appointed Vice President at PulPac   Marcus Palm joins PulPac from Välinge Innovation, where he served as Chief Legal

OrderYOYO A/S publishes first half-year report 2024 confirming earlier announced Net Revenue growth of 28% and a H1 2024 EBITDA of DKK 22.8m corresponding to +15% EBITDA margin

Company Announcement No. 76 - 2024 OrderYOYO A/SCopenhagen, August 22, 2024 Highlights Business continues to perform strongly. Highly focused strategy solving digital challenges for our Restaurant Partners continues to reap rewards to the benefit of both our Restaurant Partners and OrderYOYO June 2024 ARR is DKK 302m, highest ever realised ARR, corresponding to a growth of 23% compared to June 2023. H1 2024 Net Revenue is DKK 148m corresponding to a growth of 28% compared to H1 2023 H1 2024 EBITDA at DKK 22.8m, 153% above H1 2023 EBITDA of DKK 9.0m. H1 2024 Cash EBITDA at

Tokmanni Group Corporation: Managers' Transactions – Seppo Saastamoinen

Tokmanni Group Corporation        Managers' Transactions        22 August 2024 at 10:00 amPerson subject to the notification requirementName: Seppo SaastamoinenPosition: Member of the Board/Deputy memberIssuer: Tokmanni Group OyjLEI: 743700VMG6KWF0FW1560Notification type: INITIAL NOTIFICATIONReference number: 75115/9/10 Transaction date: 2024-08-20Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000197934Nature of transaction: ACQUISITION Transaction details (1): Volume: 30000 Unit price: 10.87 EUR Aggregated transactions (1):Volume: 30000

Publication of Solwers' January-June 2024 half-year report and invitation to webcast

Solwers Plc, Press release, 22 August 2024 at 10:00 a.m. EEST Solwers will publish its half-year report for January-June 2024 on Friday 30th August, approximately at 9.00 a.m. EEST. The half-year report release will be available in Finnish and English on the company’s website at https://solwers.com/for-investors/company-releases/.   CEO Stefan Nyström and CFO Teemu Kraus will present the company’s half-year report and current events in a live English webcast on the same day, starting at 10.00 a.m. EEST. The webcast can be followed live at https://solwers.videosync.fi/q2-2024. Audience

From Matchmaking to Market Leader: An Interview with InvitePeople’s Chief Revenue Officer

InvitePeople, a dynamic all-in-one event management platform, has rapidly established itself as a leader in the European market, particularly excelling in Germany. As a portfolio company of Katalysen Ventures, InvitePeople continues to innovate and expand its reach. In this interview, Katalysen COO Tobias Mathiasen sits down with InvitePeople’s CRO Victoria Hallin to explore the company’s journey, its current successes, and the future of the event industry in a post-pandemic world.Tobias: Victoria, thank you for joining us today. Let’s dive right in. As a veteran in the event platform

Regarding rumors of an imminent approval of lecanemab in Great Britain

Stockholm, Sweden August 22, 2024 – British media are reporting on the imminent approval of lecanemab in Great Britain. BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) has currently not been informed that the relevant authorities have made a decision and cannot therefore comment on these rumors. The company will update the market if new information becomes available.--- The information was released for public disclosure, through the agency of the contact persons below, on August 22, 2024, at 08.34 a.m. CET.  For further information, please contact: Oskar Bosson, VP Communications

There are no items matching the current filter
There are no more items matching the current filter
Back to top